Estados financieros detallados de Eledon Pharmaceuticals, Inc. (ELDN): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $2.67, ELDN presenta beneficios negativos (P/E no significativo) y un ROE del -136.45%. La capitalización bursátil es de $206M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $35000 | $22000 | $11000 | $182000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | -$35000 | -$22000 | -$11000 | -$182000 | 0 | 0 | 0 | 0 | 0 | 0 |
| I+D | $25.0M | $2.0M | $6.8M | $8.1M | $6.1M | $23.7M | $27.1M | $30.3M | $52.0M | $66.3M |
| Generales y Administrativos | $13.1M | $11.1M | $7.2M | $5.9M | $10.1M | $13.1M | $12.7M | $12.7M | $18.6M | $17.0M |
| Gastos Operativos | $38.1M | $13.1M | $14.1M | $14.0M | $18.5M | $36.9M | $88.4M | $43.0M | $70.6M | $83.3M |
| Beneficio Operativo | -$38.1M | -$13.1M | -$14.1M | -$14.2M | -$18.5M | -$36.9M | -$88.4M | -$43.0M | -$70.6M | -$83.3M |
| EBITDA | -$6.9M | -$13.1M | -$14.0M | -$15.8M | -$16.0M | -$36.7M | -$39.4M | -$116.2M | -$35.4M | -$45.3M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | $9.7M | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$38.0M | -$13.1M | -$14.1M | -$16.0M | -$23.2M | -$36.9M | -$88.0M | -$116.5M | -$35.8M | -$45.6M |
| Impuestos | $136000 | 0 | -$5000 | 0 | -$404000 | -$2.4M | 0 | 0 | $431000 | $35000 |
| Beneficio Neto | -$38.0M | -$13.1M | -$14.1M | -$16.0M | -$22.8M | -$34.5M | -$88.0M | -$116.5M | -$36.2M | -$45.6M |
| BPA | $-398.52 | $-41.40 | $-28.11 | $-24.42 | $-17.16 | $-2.33 | $-6.16 | $-4.73 | $-0.75 | $-0.56 |
| BPA Diluido | $-398.52 | $-41.40 | $-28.11 | $-24.42 | $-17.16 | $-2.33 | $-6.16 | $-4.73 | $-0.75 | $-0.56 |
| Acciones en Circulación (Diluidas) | $4.2M | $4.7M | $9.0M | $11.8M | $15.2M | $14.8M | $14.3M | $24.6M | $48.5M | $81.8M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | 0 | 0 |
| Beneficio Operativo | -$19.1M | -$21.5M | -$21.2M | -$22.9M |
| EBITDA | -$17.5M | -$10.3M | -$39.0M | -$14.1M |
| Beneficio Neto | -$17.5M | -$10.4M | -$39.0M | -$31.6M |
| BPA | $-0.23 | $-0.14 | $-0.35 | $-0.27 |
| BPA Diluido | $-0.23 | $-0.14 | $-0.35 | $-0.27 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $23.2M | $17.2M | $13.0M | $8.8M | $114.2M | $84.8M | $56.4M | $4.6M | $20.5M | $22.8M |
| Inversiones a Corto | $4.2M | 0 | 0 | 0 | 0 | 0 | 0 | $46.5M | $119.6M | $110.5M |
| Cuentas por Cobrar | 0 | 0 | $594000 | $245000 | $110000 | 0 | 0 | 0 | 0 | $514000 |
| Inventario | 0 | 0 | 0 | $881000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $29.5M | $19.0M | $14.3M | $10.0M | $115.6M | $88.3M | $59.5M | $56.1M | $143.7M | $135.7M |
| Inmovilizado Material | $98000 | $25000 | $14000 | $321000 | $138000 | $768000 | $739000 | $365000 | $926000 | $613000 |
| Fondo de Comercio | 0 | $1.9M | $1.9M | 0 | $48.6M | $48.6M | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | $32.4M | $32.4M | $32.4M | $32.4M | $32.4M | $32.4M |
| Activos Totales | $29.8M | $20.9M | $17.0M | $10.9M | $197.2M | $170.5M | $92.8M | $89.1M | $177.4M | $169.0M |
| Cuentas por Pagar | $338000 | $418000 | $689000 | $329000 | $1.4M | $1.8M | $2.2M | $967000 | $5.8M | $3.6M |
| Deuda a Corto | $3.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $2.8M | $1.4M | $2.5M | $1.3M | $2.5M | $4.4M | $6.5M | $3.9M | $11.6M | $18.3M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $2.9M | $1.4M | $2.5M | $1.5M | $6.6M | $6.6M | $8.6M | $81.9M | $59.3M | $87.9M |
| Reservas | -$169.4M | -$27.5M | -$41.6M | -$57.6M | -$80.4M | -$114.9M | -$202.9M | -$319.4M | -$355.6M | -$401.2M |
| Patrimonio Neto | $26.9M | $19.5M | $14.5M | $9.5M | $190.6M | $164.0M | $84.2M | $7.2M | $118.1M | $81.1M |
| Deuda Total | $3.4M | 0 | 0 | $324000 | $144000 | $769000 | $746000 | $383000 | $954000 | $641000 |
| Deuda Neta | -$24.0M | -$17.2M | -$13.0M | -$8.5M | -$114.1M | -$84.1M | -$55.7M | -$50.7M | -$139.2M | -$132.7M |
| Capital Circulante | $26.7M | $17.6M | $11.7M | $8.6M | $113.1M | $83.9M | $53.0M | $52.2M | $132.2M | $117.3M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $3.7M | $22.8M | $6.2M | $6.8M |
| Activos Totales | $129.9M | $169.0M | $146.7M | $126.1M |
| Pasivos Totales | $94.5M | $87.9M | $46.2M | $54.1M |
| Patrimonio Neto | $35.4M | $81.1M | $100.5M | $72.0M |
| Deuda Total | $722000 | $641000 | $555000 | $467000 |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$38.0M | -$13.1M | -$14.1M | -$16.0M | -$22.8M | -$34.5M | -$88.0M | -$116.5M | -$36.2M | -$45.6M |
| Amortizaciones | $171000 | $22000 | $11000 | $182000 | $183000 | $195000 | $373000 | $374000 | $359000 | $313000 |
| Compensación en Acciones | $3.0M | $579000 | $1.5M | $1.3M | $3.2M | $7.9M | $8.2M | $6.5M | $13.1M | $10.5M |
| Cambio en Capital Circulante | -$2.1M | -$2.5M | $618000 | -$1.2M | -$180000 | -$152000 | $2.4M | -$4.9M | $8.7M | $7.7M |
| Flujo de Caja Operativo | -$36.5M | -$14.9M | -$11.9M | -$13.9M | -$15.2M | -$28.9M | -$28.4M | -$39.5M | -$47.3M | -$62.3M |
| Inversiones (CapEx) | -$17000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adquisiciones | -$2000 | $23.2M | 0 | 0 | $11.0M | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | -$25000 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | -$25000 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$36.5M | -$14.9M | -$11.9M | -$13.9M | -$15.2M | -$28.9M | -$28.4M | -$39.5M | -$47.3M | -$62.3M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$14.5M | -$14.1M | -$22.6M | -$22.7M |
| Inversiones (CapEx) | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$14.5M | -$14.1M | -$22.6M | -$22.7M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $2.4M | $2.5M | $2.2M | $3.2M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Beneficio Neto (anual) | | +65.4% | -7.2% | -13.8% | -42.5% | -51.3% | -154.9% | -32.5% | +69.0% | -26.1% |
| Crecimiento BPA (anual) | | +89.6% | +32.1% | +13.1% | +29.7% | +86.4% | -164.4% | +23.2% | +84.1% | +25.3% |
| Cambio en Acciones (anual) | | +12.6% | +92.5% | +31.0% | +28.5% | -2.2% | -3.6% | +72.3% | +97.2% | +68.6% |
| Crecimiento FCF (anual) | | +59.1% | +20.4% | -16.5% | -9.8% | -90.1% | +1.7% | -39.1% | -19.6% | -31.9% |
| Tasa Impositiva Efectiva | -0.4% | -0.0% | 0.0% | -0.0% | 1.7% | 6.4% | -0.0% | -0.0% | -1.2% | -0.1% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-8.79 | $-3.19 | $-1.32 | $-1.17 | $-1.00 | $-1.95 | $-1.99 | $-1.61 | $-0.97 | $-0.76 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $4.2M | $4.7M | $9.0M | $11.8M | $15.2M | $14.8M | $14.3M | $24.6M | $48.5M | $81.8M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -136.45% |
| Rentabilidad sobre capital invertido | -73.77% |
| Rentabilidad sobre activos | -78.16% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.01 |
| Ratio corriente | 7.90 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -0.40 | -1.77 | -1.02 | -0.43 | -0.90 | -1.89 | -0.37 | -0.38 | -5.49 | -2.70 |
| P/VC | 24.51 | 17.57 | 17.90 | 13.01 | 1.22 | 0.40 | 0.39 | 6.15 | 1.69 | 1.52 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |